Neptune Wellness Solutions (NASDAQ:NEPT) Receives New Coverage from Analysts at StockNews.com

StockNews.com initiated coverage on shares of Neptune Wellness Solutions (NASDAQ:NEPTGet Rating) (TSE:NTB) in a research note released on Thursday morning. The firm issued a sell rating on the biotechnology company’s stock.

Separately, Zacks Investment Research cut shares of Neptune Wellness Solutions from a buy rating to a hold rating in a report on Wednesday, April 13th.

NASDAQ:NEPT opened at $0.17 on Thursday. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.07 and a current ratio of 1.75. The firm has a fifty day simple moving average of $0.23 and a two-hundred day simple moving average of $0.35. Neptune Wellness Solutions has a 12 month low of $0.16 and a 12 month high of $1.49.

Neptune Wellness Solutions (NASDAQ:NEPTGet Rating) (TSE:NTB) last posted its quarterly earnings results on Thursday, February 10th. The biotechnology company reported ($0.09) EPS for the quarter, missing analysts’ consensus estimates of ($0.06) by ($0.03). The company had revenue of $14.63 million during the quarter, compared to analyst estimates of $13.64 million. Neptune Wellness Solutions had a negative return on equity of 73.19% and a negative net margin of 207.14%. Equities research analysts anticipate that Neptune Wellness Solutions will post -0.32 earnings per share for the current year.

Several hedge funds and other institutional investors have recently modified their holdings of NEPT. Virtu Financial LLC acquired a new position in shares of Neptune Wellness Solutions during the fourth quarter valued at about $64,000. Natixis purchased a new position in Neptune Wellness Solutions during the third quarter worth about $69,000. Morgan Stanley boosted its holdings in Neptune Wellness Solutions by 31.8% during the second quarter. Morgan Stanley now owns 141,269 shares of the biotechnology company’s stock worth $166,000 after purchasing an additional 34,123 shares during the last quarter. Renaissance Technologies LLC purchased a new position in Neptune Wellness Solutions during the fourth quarter worth about $184,000. Finally, Commonwealth Equity Services LLC boosted its holdings in Neptune Wellness Solutions by 7.1% during the first quarter. Commonwealth Equity Services LLC now owns 1,343,546 shares of the biotechnology company’s stock worth $298,000 after purchasing an additional 88,755 shares during the last quarter. Hedge funds and other institutional investors own 8.89% of the company’s stock.

Neptune Wellness Solutions Company Profile (Get Rating)

Neptune Wellness Solutions Inc, a health and wellness products company, specializes in the extraction, purification and formulation of cannabis products, as well as other specialty ingredients, such as MaxSimil, a patented ingredient that enhances the absorption of lipid-based nutraceuticals, and various other marine and seed oils.

Recommended Stories

Receive News & Ratings for Neptune Wellness Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neptune Wellness Solutions and related companies with MarketBeat.com's FREE daily email newsletter.